W.R. Berkley Corp’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.42K Hold
17,254
﹤0.01% 344
2025
Q4
$4.83K Hold
17,254
﹤0.01% 284
2025
Q3
$5K Sell
17,254
-69,511
-80% -$18.8K ﹤0.01% 233
2025
Q2
$20K Hold
86,765
﹤0.01% 212
2025
Q1
$12.2K Buy
+86,765
New +$15.3K ﹤0.01% 148

Other funds holding TDACW

W.R. Berkley Corp's TDACW Position: Q1 2026 in Review

W.R. Berkley Corp held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q1 2026 at 17,254 shares worth $2.42K. The position accounts for ﹤0.01% of the portfolio, ranked #344.

W.R. Berkley Corp first reported a position in TDACW in Q1 2025 and has held it in 5 quarters since. The position peaked at $20K in Q2 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • W.R. Berkley Corp held 17,254 shares of Translational Development Acquisition Corp Warrants worth $2.42K as of Q1 2026.
  • W.R. Berkley Corp left its Translational Development Acquisition Corp Warrants share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of W.R. Berkley Corp's portfolio in Q1 2026, its #344 holding.
  • W.R. Berkley Corp first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 5 quarters since.
  • W.R. Berkley Corp's Translational Development Acquisition Corp Warrants position peaked at $20K in Q2 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on W.R. Berkley Corp's 13F filing for Q1 2026, filed 15 May 2026.